Prof Jude Curran Inaugural lecture

Prof Jude Curran Inaugural Lecture: The Appliance of Bioinspired Science - Keeping Relevant in a Changing World.

5:30pm - 6:30pm / Thursday 28th September 2023 / Venue: Victoria Gallery & Museum
Type: Lecture / Category: Department / Series: Liverpool Women in Science and Engineering
Add this event to my calendar

Create a calendar file

Click on "Create a calendar file" and your browser will download a .ics file for this event.

Microsoft Outlook: Download the file, double-click it to open it in Outlook, then click on "Save & Close" to save it to your calendar. If that doesn't work go into Outlook, click on the File tab, then on Open & Export, then Open Calendar. Select your .ics file then click on "Save & Close".

Google Calendar: download the file, then go into your calendar. On the left where it says "Other calendars" click on the arrow icon and then click on Import calendar. Click on Browse and select the .ics file, then click on Import.

Apple Calendar: The file may open automatically with an option to save it to your calendar. If not, download the file, then you can either drag it to Calendar or import the file by going to File >Import > Import and choosing the .ics file.

This talk will present the most recent advances in a number of active research projects including the role of surface engineering in bone and neuronal tissue engineering applications.

It will also cover Professor Jude Curran's work on the standardisation of in vitro test regimes and recent advancements in the design and optimisation of tri-functional nanosensors that have the ability to quantify O2, pH and glucose in real-time through 3D cell-testing regimes.

The application and combination of fundamental biological and engineering science to the development of cost-effective standardised test regimes has been key to developing fundamental concepts from the bench to real-world scenarios.

Finally, the talk will present the latest developments in cost-effective, real-time, label-free tracking of nonentities through biological solutions, and the application of this platform technology to pre-clinical testing regimes and models of infection. This has the potential to expedite new drug discovery and anti-microbial/viral therapies.